HOLX - ホロジック (Hologic Inc.) ホロジック

 HOLXのチャート


 HOLXの企業情報

symbol HOLx
会社名 Hologic Inc (ホロジック)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical Electronics  
業種 先端医療機器_テクノロジ―   医療関連(Health Care)
概要 事業概要 ホロジック(Hologic Inc.)は女性のヘルスケアニーズに応える診断製品、医療用画像処理システム及び外科製品の開発・製造・提供に従事する会社。同社は診断、乳房健康、産婦人科(GYN)手術及び骨格健康という4つの事業部門を運営する。同社の診断製品は、APTIMAアッセイ系製品、ThinPrepシステム、ラピッド胎児性フィブロネクチン及びProcleix血液スクリーニングアッセイを含む。同社はB型肝炎ウイルス(HBV)、C型肝炎ウイルス(HCV)及びヒト免疫不全ウイルス-1(HIV-1)の定量のためのウイルス負荷のアッセイを提供する。乳房健康の製品は、デジタル式乳房撮影システム、コンピュータ支援診断(CAD)及び乳房生検のガイダンスシステムなどの乳房画像と関連する製品・アクセサリーを含む。GYN手術製品は、NovaSure子宮内膜アブレーションシステムとMyoSure子宮筋腫切除システムを含む。骨格健康部門は、Discovery・Horizon X線骨密度測定装置とミニCアーム撮像システムを提供する。   ホロジックは米国の医療機器製造会社。遺伝子関連試薬、医薬品、診断薬、医療機器、理化学機器などの研究開発・製造・販売を手掛ける。主な製品は「NovaSure」子宮内膜アブレ―ションシステムや「MyoSure」子宮筋腫除去システム、ホライゾン骨濃度計など。本社はマサチュ―セッツ州ベッドフォ―ド。   Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment.
本社所在地 250 Campus Drive Marlborough MA 01752 USA
代表者氏名 Stephen P. MacMillan スティーブン・P・マクミラン
代表者役職名 Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者(CEO)
電話番号 +1 508-263-2900
設立年月日 31321
市場名 NASDAQ National Market System
ipoyear 1990年
従業員数 6233人
url www.hologic.com
nasdaq_url https://www.nasdaq.com/symbol/holx
adr_tso
EBITDA EBITDA(百万ドル) 999.60000
終値(lastsale) 40.67
時価総額(marketcap) 11067232974.56
時価総額 時価総額(百万ドル) 11110.77
売上高 売上高(百万ドル) 3207.3
企業価値(EV) 企業価値(EV)(百万ドル) 13805.57
当期純利益 当期純利益(百万ドル) -433.60000
決算概要 決算概要 BRIEF: For the nine months ended 30 June 2018 Hologic Inc. revenues increased 7% to $2.4B. Net loss before extraordinary items totaled $516.3M vs. income of $672.8M. Revenues reflect Medical Aesthetics segment increase from $126M to $268.5M Breast Health segment increase of 7% to $896M Skeltal Health segment increase of 4% to $66.8M Europe segment increase of 27% to $284.4M United States segment increase of 2% to $1.8B.

 HOLXのテクニカル分析


 HOLXのニュース

   Abbott’s revised guidance prompts model update for COVID-19 test makers at UBS  2021/06/02 15:58:01 Seeking Alpha
   Green's Portfolio - May 2021  2021/05/31 21:40:32 Seeking Alpha
   MedTech Round Up: Update On Products By Biomerica, 908 Devices, Ekso Bionics, Hologic  2021/05/11 20:38:55 Benzinga
Biomerica Inc (NASDAQ: BMRA ) has announced that its new COVID-19 Antigen Rapid Test can now be performed with a simple, less invasive nasal swab. The test is highly portable, cost-effective, and provides results in 15 minutes versus lab-run PCR tests, taking up to three days for results. Price Action: BMRA shares closed 17.3% lower at $3.41 on Tuesday. 908 Devices Inc (NASDAQ: MASS ) has announced updates to its MX908 handheld mass spec device , including an aerosol module … Full story available on Benzinga.com
   Facebook, Qualcomm rise; Merck, Hologic fall  2021/04/29 20:17:45 ABC News
Stocks that traded heavily or had substantial price changes Thursday: Facebook, Qualcomm rise; Merck, Hologic fall
   Hologic Shares Drop On Q2 Earnings Miss; Q3 Guidance Trail Consensus  2021/04/29 13:20:20 Benzinga
Hologic Inc (NASDAQ: HOLX ) posted second-quarter results that trailed the consensus forecast; however, the company tried to provide some cushion with a better third-quarter fueled by COVID-19 test revenue. Q2 adjusted EPS of $2.59 missed the consensus of $2.61, while sales of $1.54 billion were roughly in-line. Molecular diagnostics revenue of $935.3 million increased 390.6%, or 378.4% in constant currency, based on robust demand for its two SARS-CoV-2 assays that run on the fully automated Panther and Panther Fusion systems. “Hologic posted very strong financial results in our second fiscal quarter in line with our guidance,” said Steve MacMillan, the company’s CEO. “Organic revenue doubled, driven by strong recovery and … Full story available on Benzinga.com
   Hologic winst lager dan voorspeld, omzet volgens verwachting  2021/04/28 20:08:58 Investing.com Netherlands
   Hologic Strengthens Diagnostics Business With $795M Mobidiag Deal  2021/04/08 14:36:09 Benzinga
Hologic Inc (NASDAQ: HOLX ) has agreed to acquire Mobidiag Oy , a privately held, Europe-based provider of molecular diagnostic tests and instrumentation, for an enterprise value of approximately $795 million. The deal includes a cash payment of approximately $714 million (€600 million) for Mobidiag's equity and net debt of roughly $81 million. Mobidiag develops and markets PCR … Full story available on Benzinga.com
   Hologic : to Webcast Presentations at Upcoming Virtual Investor Conferences | MarketScreener  2021/02/10 21:07:04 MarketScreener
Hologic, Inc. announced today that the Company will present at these upcoming virtual investor conferences: The BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference… | February 10, 2021
   Hologic to Webcast Presentations at Upcoming Virtual Investor Conferences  2021/02/10 21:05:00 Business Wire
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #holx--Hologic to Webcast Presentations at Upcoming Virtual Investor Conferences
   Hologic bets on machine learning to improve cervical cancer screening  2021/02/08 18:00:00 BioWorld
Hologic Inc. is teaming up with Google Cloud to use machine learning technologies to improve the accuracy and timeliness of cytology for cervical cancer screening. Marlborough, Mass.-based Hologic, which makes both Pap and human papillomavirus (HPV) assays, is already using artificial intelligence (AI) and machine learning in its new digital cytology platform that is available in Europe. The multiyear collaboration with Mountain View, Calif.-based Google Cloud will start with innovating that product further by enhancing the deep learning component of the system.
   Apple, FedEx, Ford, Hologic and Weyerhaeuser  2021/02/08 15:31:03 Tech Fans
For Immediate ReleaseChicago, IL – February 8, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Resear
   Non-Invasive Cancer Diagnostics Market Major Players Roche Diagnostics, Hologic Inc., Qiagen, Gen-Probe Inc., Digene Corporation, Abbott Molecular, IVDiagnostics, Laboratory Corporation of America Holdings, OncoCyte Corporation, Arquer Diagnostics Ltd. an  2021/02/05 09:07:20 OpenPR
CMI published a business research report on Non-Invasive Cancer Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2020–2026. Non-Invasive Cancer Diagnostics Market with 150+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy

 関連キーワード  (先端医療機器_テクノロジ― 米国株 ホロジック HOLX Hologic Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)